tradmap

PODD Financials Insulet Corporation

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 24.5% per year over the past 5 years.
  • Net income has grown faster than revenue (105.2% vs 24.5% per year).
  • Operating margin has expanded, at 17.5% in the latest year.

Financial health

  • Total debt has grown slower than revenue (19.9% vs 24.5% per year).
  • Operating income covered interest expense 8.0× in the latest year.
Revenue & net income
-$74M $1B $3B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-28% 22% 72% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-216% -91% 35% 0% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$180M $99M $378M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $701M $1B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$595M $5M $606M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $2.7B $247M 71.6% 17.5% 16.3% 7.7% $378M — $716M
2024 $2.1B $418M 69.8% 14.9% 34.5% 13.5% $305M — $953M
2023 $1.7B $206M 68.3% 13.0% 28.2% 8.0% $70M — $704M
2022 $1.3B $5M 61.7% 2.9% 1.0% 0.2% -$4M $1.4B $690M
2021 $1.1B $17M 68.4% 11.5% 3.0% 0.8% -$180M $1.3B $806M
2020 $904M $7M 64.4% 5.7% 1.1% 0.4% -$45M $1.1B $922M
2019 — $12M — — 15.3% 1.0% -$65M $888M $214M
2018 — $3M — — 1.6% 0.4% -$122M $592M $114M
2017 $464M -$27M 59.8% -1.6% -16.9% -3.3% -$33M $566M $273M
2016 $367M -$29M 57.5% -2.9% -45.8% -6.3% -$6M $333M $137M
2015 $264M -$74M 50.5% -18.5% -215.9% -26.7% -$23M $172M $123M
2014 $231M -$52M 55.0% -3.8% -61.4% -17.3% -$3M $164M $151M
2013 — -$45M — — -36.1% -15.6% -$4M $114M —
2012 — -$52M — — -117.4% -26.2% -$40M $118M —
2011 — -$46M — — -55.4% -20.7% -$37M $109M —

Valuation over time

How the market has priced PODD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 2404.6 4809.3 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 8.5 16.9 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is PODD growing its revenue and profit?

Over the past 5 years, Insulet Corporation's revenue has grown 24.5% per year, and net income grown 105.2% per year. These are computed facts, not advice.

How much debt does PODD have?

As of FY2025, Insulet Corporation reported — of total debt against $716M of cash; operating income covered interest expense 8.0×.

What is PODD's profit margin?

In FY2025, gross margin was 71.6%, operating margin 17.5%, and net margin 9.1%.

What is PODD's P/E ratio?

Insulet Corporation's P/E (TTM) is 28.39 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the PODD stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 43.1× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.